Fluconazole Prophylaxis and Treatment Guidelines

Introduction to Fluconazole Use

The American College of Physicians and the Infectious Diseases Society of America recommend that routine fluconazole prophylaxis is NOT indicated for immunocompetent patients taking antibiotics, even with a history of recurrent yeast infections, as antibiotics alone do not constitute sufficient risk for invasive candidiasis requiring prophylaxis 1

For vulvovaginal candidiasis, a single dose of fluconazole 150 mg orally is recommended for uncomplicated cases, with clinical cure rates exceeding 90% with single-dose therapy 2
For oropharyngeal candidiasis, mild disease can be treated with clotrimazole troches 10 mg 5 times daily for 7-14 days, while moderate-severe disease requires fluconazole 100-200 mg daily for 7-14 days 3, 4
For urinary tract candidiasis, treatment is NOT recommended for asymptomatic candiduria in immunocompetent patients, but symptomatic cystitis can be treated with fluconazole 200 mg daily for 2 weeks 3, 5

Neutropenic patients should receive fluconazole 400 mg daily during chemotherapy-induced neutropenia, continuing throughout the period of neutropenia risk 6
ICU patients with multiple risk factors may receive fluconazole 800 mg loading dose, then 400 mg daily, but only in units with high invasive candidiasis incidence 6
Bone marrow transplant recipients should receive fluconazole 400 mg daily starting several days before anticipated neutropenia, and continuing for 7 days after neutrophil count rises above 1000 cells/mm³ 6
Solid organ transplant recipients at high risk may receive fluconazole 200-400 mg daily 6

For patients with documented recurrent vulvovaginal candidiasis (≥4 episodes per year), fluconazole 150 mg weekly for 6 months is recommended for maintenance therapy, reducing recurrence rate from 64% to 9% at 6 months 2

Fluconazole prophylaxis in immunocompetent patients promotes resistance without proven benefit, and should not be used routinely 1
Eliminating indwelling bladder catheters is crucial, as continuing catheters during treatment significantly reduces cure rates 5, 4
Monitoring for resistance is essential, as C. glabrata may develop fluconazole resistance during therapy, requiring a switch to amphotericin B deoxycholate 0.3-0.6 mg/kg daily for 1-7 days 3, 5